Domů › Kolorektální karcinom › Nebraska › Omaha
Klinické studie Kolorektální karcinom v Omaha, NE
18 studií pro Kolorektální karcinom hledá účastníky v lokalitách v Omaha a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Family Communications After Genetic Testing
Probíhá náborVítáni zdraví dobrovolníci
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Probíhá náborFáze 2
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · Vzdálenost 9 mi
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Probíhá náborFáze 1
- Exelixis Clinical Site #2, Omaha
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Probíhá náborFáze 1/2
- Nebraska Cancer Specialists, Omaha
- XCancer, Omaha
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Probíhá náborFáze 2
- Nebraska Cancer Specialists - Omaha - Wright Street /ID# 271646, Omaha
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Probíhá náborFáze 3
- Nebraska Cancer Specialists, Omaha
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Probíhá náborFáze 3
- Nebraska Cancer Specialists Midwest Cancer Center, Omaha
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Probíhá náborFáze 2/3
- University Of Nebraska Medical Center, Omaha
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Probíhá náborFáze 1/2
- Nebraska Cancer Specialists, Omaha
- University of Nebraska Medical Center, Omaha
Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease
Probíhá náborFáze 3
- Oncology Hematology West, PC dba Nebraska Cancer Specialists - Methodist, Omaha
- Oncology Hematology West, PC dba Nebraska Cancer Specialists - Bergan, Omaha
- Oncology Hematology West, PC dba Nebraska Cancer Specialists - Legacy, Omaha
- a dalších 2
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)
Probíhá náborFáze 1
- Nebraska Cancer Specialists, Omaha
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Probíhá náborFáze 2
- Nebraska Cancer Specialists, Omaha
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Probíhá náborFáze 1/2
- Nebraska Cancer Specialists, Omaha
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Probíhá náborFáze 1
- Nebraska Cancer Specialists (Midwest Cancer Center - Legacy), Omaha
- XCancer Omaha / Urology Cancer Center, Omaha
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Probíhá náborFáze 3Vítáni zdraví dobrovolníci
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
- a dalších 1
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1/2
- Nebraska Cancer Specialists, Omaha
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Probíhá náborObservační studie
- Nebraska Cancer Specialists, Omaha
Studie Kolorektální karcinom v jiných městech
- Houston, TX102 studií
- New York City, NY78 studií
- Nashville, TN69 studií
- Boston, MA63 studií
- Los Angeles, CA59 studií
- Arlington, VA52 studií
- St. Louis, MO50 studií
- San Antonio, TX46 studií
- Philadelphia, PA44 studií
- Grand Rapids, MI40 studií
- Baldwin Park, CA37 studií
- Chicago, IL34 studií
Další studie v Omaha
- Rakovina prostaty27 studií
- Nemalobuněčný plicní karcinom24 studií
- Rakovina prsu22 studií
- Rakovina (všechny typy)18 studií
- Mnohočetný myelom16 studií
- Rakovina vaječníků14 studií
- Non-Hodgkinův lymfom14 studií
- Rakovina slinivky břišní14 studií
- Metastatický karcinom13 studií
- Squamózní buněčný karcinom hlavy a krku13 studií
- Srdeční selhání13 studií
- Melanom12 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.